Travel of Special Envoy for the Sahel Region Dr. J. Peter Pham to Mali

30 Sep

Office of the Spokesperson

Special Envoy for the Sahel Region Dr. J. Peter Pham will travel to Bamako, Mali from September 30 to October 3.  The Special Envoy will meet with the transitional government as well as civil society, religious leaders, and officials from the United Nations, African Union, G5 Sahel and the diplomatic community.  He will urge the transitional government to honor the commitments it has made to the Economic Community of West African States (ECOWAS), including holding free and fair elections within 18 months.   He will also encourage efforts to combat corruption, address human rights concerns, reform electoral processes, and implement the 2015 Agreement for Peace and Reconciliation in Mali.

Uncategorised

Joint Statement on the Japan-United States Strategic Energy Partnership (JUSEP)

30 Sep

Office of the Spokesperson

The text of the following statement was released by the Governments of the United States of America and Japan on the occasion of the Japan-United States Strategic Energy Partnership (JUSEP).

Begin Text:

Japan and the United States reaffirmed their joint commitment to maintaining open and competitive energy markets and strengthening energy security in the Indo-Pacific region at a virtual Japan-United States Strategic Energy Partnership (JUSEP) meeting on September 24 (EST)/25 (JST), 2020.  Both sides praised this year’s JUSEP achievements and recognized the importance of ongoing bilateral energy cooperation with an emphasis on LNG and emerging energy technology.  In addition, while working to mitigate the global effects of COVID-19, each country highlighted the progress of U.S.-Japan joint projects and discussed the importance of continued commercial engagement. The two governments also reviewed progress under the Japan-U.S.-Mekong Power Partnership (JUMPP) to strengthen Mekong power sectors, detailed in the Japan-U.S. Joint Ministerial Statement on JUMPP released on September 8, 2020 and Mekong-U.S. Partnership Joint Ministerial Statement released on the occasion of the First Mekong-U.S. Partnership Ministerial Meeting on September 11, 2020. Looking to the future, the United States and Japan discussed plans to hold a public-private event in the Indo-Pacific region in the coming months, and to further develop JUSEP to include a wider range of energy technology.

End Text.

Uncategorised

Trump’s Failed Coronavirus Response On Full Display At Last Night’s Debate

30 Sep

Trump’s failed coronavirus response was on full display last night as he downplayed the virus, dismissed experts, politicized the vaccine approval process, and defended his rallies that put more Americans at risk. Trump failed to respond to the pandemic and he continues to fail to lead or even make a plan to contain the virus. As Biden said to Trump, “It is what it is because you are who you are.”

Trump continues to ignore the experts and puts his ego ahead of public health by holding rallies in dangerous coronavirus “red zones.”

USA Today: “Asked why he continues to hold large rallies against the advice of his own health experts, Trump responded: ‘Because people want to hear what I have to say.’”

Washington Post: “President Trump has scheduled large campaign rallies this weekend in Wisconsin despite recommendations from the White House Coronavirus Task Force that call for increasing social distancing in the state ‘to the maximal degree possible.’ The task force has further flagged La Crosse and Green Bay, the metropolitan areas where Trump plans to gather thousands of supporters Saturday, as coronavirus ‘red zones,’ the highest level of concern for community spread of the virus, according to a report from the group released Sunday and obtained by The Washington Post.”

Trump continues to downplay the importance of wearing masks and has fallen far short of his goal to supply enough masks in time for flu season.

The Hill: “President Trump on Tuesday downplayed the importance of wearing masks, saying the administration’s top scientists have changed their minds about it.”

Yahoo News: “The Trump administration is falling far short of its goal of having 300 million N95 respirators available in time for the flu season, according to internal documents reviewed by Yahoo News.”

Trump continues to politicize the vaccine approval process and undermines the credibility of the FDA, which they need to ensure public trust.

STAT: “Trump’s debate highlights his hunger for a rushed, election-eve vaccine approval”

Washington Post: “7 former FDA commissioners: The Trump administration is undermining the credibility of the FDA”

Trump continues to downplay the threat of coronavirus to young people and children as more evidence comes out that they can spread the virus.

TRUMP: “Now we’ve found that elderly people with heart problems and diabetes and different problems are very, very vulnerable. We learned a lot. Young children aren’t, even younger people aren’t.”

NPR: “When Young People Get COVID-19, Infections Soon Rise Among Older Adults”

Associated Press: “COVID-19 cases rising among US children as schools reopen”

ABC News: “Evidence is mounting that children may play a larger role in the community spread of COVID-19, according to two studies. The American Academy of Pediatrics and the Children’s Hospital Association published a study on Tuesday that showed that the number of children infected with COVID-19 rose sharply from April to September.”

The post Trump’s Failed Coronavirus Response On Full Display At Last Night’s Debate appeared first on Democrats.

What They’re Reading: Trump’s “Shameful” Debate Performance Called Out In The Battlegrounds, Press

30 Sep

Argumentative,” “shameful,” “a reason to vote for Joe Biden” — that’s what voters in the battlegrounds are reading in their local news outlets about Trump’s disastrous debate performance. See for yourself:

In Arizona: 

Arizona Republic: “‘Joe Biden met the bar,’ said Kirk Adams, a Republican and former chief of staff to Arizona Gov. Doug Ducey … ‘If you’re looking for a reason to vote for Joe Biden, or if you’re looking for a reason to not vote for Donald Trump, you might have gotten it tonight.’”

In Georgia:

Atlanta Journal-Constitution: “[University of Georgia Communication Professor Edward Panetta]: “Trump did little to address the concerns of white, college-educated women in the suburbs who are concerned about the president’s behavior. These are the voters who left the Republican Party in the 2018 election cycle.”

In Nevada:

KTNV: “One issue in particular struck a chord with viewers from both parties … ‘200 thousand deaths. That’s a lot,’ said [local resident Ben] Barteau.”

In Michigan:

Detroit Free Press: “Ronda Clements, 60, of West Bloomfield, an undecided voter and retired worker for the state: ‘President Trump … had no direct answers to any of the questions. He was argumentative toward the moderator and Vice President Biden and did not allow the debate to be conducted correctly … President Trump did not allow the public to hear (the answers). (He) focused on what others have done and not what he plans to do if he wins the election.’”

WXYZ: Metro Detroit voters react to first 2020 presidential debate: ‘I found it very painful to watch.’ “‘I just felt like he was kind of a bully, Trump. And just bulldozed over everybody, the moderator and Joe Biden,’ [said Florencia Solis of Oak Park]. ‘Maybe they should start turning off the microphone off who’s not supposed to be talking to allow the other person to talk.”

In New Hampshire:

WMUR: “‘Donald Trump made a mockery of this. It was shameful.’”

Boston Globe: Editorial Board: It wasn’t a debate. It was a national embarrassment. “Much like the Trump presidency, it was a national embarrassment. It was an embarrassment before Trump again refused to condemn white supremacists, a travesty before a frustrated Joe Biden, the Democratic presidential nominee, addressed Trump and spoke for a weary nation: ‘Will you shut up, man?’ Biden, the former vice president, did what he could. But this was no place for civility, rules of order, detailed policy discussions or, as Pelosi predicted, truth or facts — not with Trump at the other podium.”

In Ohio:

Cleveland.com: “Trump, seeking to lift what appear to be waning re-election prospects, was looking for a boost, with advisers saying beforehand he was taking debate prep seriously. Instead, the public was greeted by Trump largely reverting to his normal routine – interrupting, name calling and outright ignoring the topics at hand. In fact, the debate got so bad, Wallace was forced to give Trump a stern talking-to.”

In Pennsylvania: 

Penn Live: “Matt Flinchbaugh is a big Donald Trump supporter. But he didn’t have big praise for the president’s performance during his debate against Democratic challenger Joe Biden on Tuesday night … Asked what Trump had done to help his case in a close election, Flinchbaugh, 42, said ‘absolutely nothing.’”

Pennsylvania Capital-Star: “His partisans may celebrate it, but the pure fact of the matter is that Trump was revealed for what he is: a thug with a paper-thin ego, who is so afraid of losing, that he tried to bluster through the paucity of his achievements, to downplay the unfathomable tragedy of the pandemic, and to take a sledgehammer to the underpinnings of our electoral system. Biden, generally, kept his cool. But, speaking for all of us, at one point, he snapped ‘Will you shut up, man?’”

In Texas:

San Antonio Express-News: “If Trump’s goal was to create havoc and get his most rabid loyalists howling in glee, he succeeded. If he wanted to persuade anyone that the next four years under his leadership will be calmer and more hopeful, he failed miserably.”

The post What They’re Reading: Trump’s “Shameful” Debate Performance Called Out In The Battlegrounds, Press appeared first on Democrats.

UN welcomes nearly $1 billion in recent pledges – to bolster access to lifesaving tests, treatments and vaccines to end COVID-19

30 Sep

New commitments from governments, international organizations and the private sector support unified approach to end pandemic, backing a response of unprecedented scale, scope and speed­—through the Access to COVID-19 Tools Accelerator­—as pandemic claims more than 1 million lives

Recent Commitments at a Glance:

  • United Kingdom – £571m (US$ 732m) for COVAX pillar of the Access to COVID-19 Tools- (ACT) Accelerator, of which up to £500m (US$ 641m) is to support low- and middle-income countries. This includes a commitment to match £1 for every US$ 4 committed by others up to £250m (US$ 321m).
  • Canada - CAD 440m (US$ 332m) for the COVAX pillar of the ACT-Accelerator, of which CAD 220 (US$ 166m) is to support low & middle income countries 
  • Germany - EUR 100m (US$ 117m) for the COVAX pillar of the ACT-Accelerator, all of which is to support low and middle income countries 
  • Sweden - US$ 10m for the COVAX pillar of the ACT-Accelerator, all of which is to support low and middle income countries 
  • World Bank – US$ 12 billion to support developing countries to purchase COVID-19 vaccines as soon as they are available (to be ratified by their shareholders)
  • A coalition of 16 pharmaceutical companies and the Bill & Melinda Gates Foundation signed an agreement to cooperate on vaccine manufacturing and to scale up production

The United Nations and its partners today welcomed a monumental show of solidarity as governments, private sector, civil society and international organizations committed support to the Access to COVID-19 Tools- (ACT) Accelerator initiative launched by the World Health Organization alongside international partners.

Today, nearly US$1 billion in new financing has been committed to the initiative - the world’s most comprehensive multilateral end-to-end solution to the devastating COVID-19 pandemic.

The ACT-Accelerator, which was co-launched by the World Health Organization, European Commission, France and the Bill & Melinda Gates Foundation just five months ago, needs an additional US$35 billion to realize its goals of producing 2 billion vaccine doses, 245 million treatments and 500 million tests. The new commitments to the initiative are welcome and will be leveraged to catalyze further funding to continue the ACT-Accelerator’s groundbreaking work. 

Most urgently, the ACT-Accelerator requires US$15 billion to support immediate capacity-building—for research and development, manufacturing, procurement and delivery systems—by the end of the year. 

Convening a high-level event at the 75th Session of the UN General Assembly to urgently mobilize support for the ACT-Accelerator, Secretary-General António Guterres commended on the “extraordinary international effort to address a human crisis like no other in our lifetimes,” adding that more efforts must be made to further “deepen” the remarkable progress so far. 

“It is in every country’s national and economic self-interest to work together to massively expand access to tests and treatments, and to support a vaccine as a global public good—a “people’s vaccine” available and affordable for everyone, everywhere.” 

”The ACT-Accelerator—including its COVAX Facility—is the vehicle to get us there. Investing in the ACT-Accelerator will accelerate every country’s own recovery,” said Mr. Guterres who co-hosted the event with the United Kingdom’s Foreign Secretary Dominic Raab, South Africa’s Health Minister Zweli Mkhize, and the Director-General of World Health Organization, Dr. Tedros Adhanom Ghebreyesus.

Unprecedented Global Collaboration

The ACT-Accelerator, which was launched just five months ago, is an unprecedented global collaboration of the world’s top international health organizations working together to accelerate the development, production, and equitable delivery of COVID-19 tests, treatments, and vaccines.  

“We have a duty to ensure vaccines, treatments and tests for COVID-19 are available to all—stopping the global spread of the pandemic protects the British people and will put humanity on the road to recovery. Collaboration through the ACT-Accelerator is critical to promoting development, production and access for all countries,” said UK Foreign Secretary Dominic Raab. 

The United Kingdom recently committed up to £571m (approximately US$ 732m) for COVAX. This includes up to £500m for the Gavi Advanced Market Commitment for COVID-19 (COVAX AMC) vaccines—a financing instrument that incentivises vaccine manufacturers to produce sufficient COVID-19 vaccines to ensure access for developing countries.

Today, the UK Foreign Secretary called for more support, pledging that this £500m commitment would include £1 (IS$ 1.29) in matched funding for every US$4 committed by others for up to £250m (approximately US$ 321m). 

Germany, Canada and Sweden have also made new commitments to the COVAX AMC of Euro 100 million, CAD$ 220 million and US$ 10 million respectively. These are eligible for matching with today’s UK matching commitment.

”Science is giving us solutions, in the form of new tests, therapeutics and­—hopefully—a vaccine. But science and solutions will be ineffective without solidarity,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. 

“I am grateful for the generous financial commitments made today, but we still have a significant funding gap to close. Fully financing the ACT Accelerator will help to control the pandemic, restore confidence and stimulate the global recovery. Frankly, this is not a financial challenge, it’s a test of solidarity. This is a moment for saying no to nationalism and yes to our shared humanity. Because ultimately, the ACT Accelerator is not delivering merely vaccines, diagnostics and therapeutics. It’s delivering something far more important—hope.”

“We must confront this health crisis as a global challenge, together in solidarity and cooperation with one another, working toward a global solution. We have to generate the key tests, treatments and vaccines that we all need, and make sure they are distributed equitably to people who most need them, regardless of where they live and whether their country is wealthy or not,” said South Africa’s Health Minister Zweli Mkhize, adding that large parts of the population especially in developing countries remain “vulnerable and marginalized during this pandemic.” 

Today’s event highlighted the substantial results achieved by the Access to COVID-19 Tools Accelerator initiative since its launch: the availability of 120 million affordable and high-quality rapid tests for low- and middle-income countries; a breakthrough in trials with, and a rapid rollout of, Dexamethasone—the only drug found to make a significant difference to patient mortality; the creation of the COVAX Facility – the global mechanism to ensure equitable access to eventual COVID-19 vaccines regardless of income -comprising  168 economies and the largest and most diverse vaccine portfolio in the world, with nine candidate vaccines under evaluation, eight of them in clinical trials. 

In another significant show of support, a coalition of 16 pharmaceutical companies and the Bill & Melinda Gates Foundation signed an agreement to cooperate on vaccine manufacturing and to scale up production at an unprecedented speed, ensuring that approved vaccines are more broadly accessible and distributed as early as possible.  

Bill Gates, Co-Chair of the Bill & Melinda Gates Foundation said “One thing I've learned studying the history of pandemics is that they create a surprising dynamic when it comes to self-interest and altruism. Pandemics are rare cases where a country’s instinct to help itself is tightly aligned with its instinct to help others. The self-interested thing and the altruistic thing–making sure poor nations have access to vaccines–are one and the same.”

“A number of countries, most recently the United Kingdom and Canada, are good models for what other wealthy nations should do. They have donated enough money for COVAX, the vaccine pillar of the ACT-Accelerator, to procure, probably, hundreds of millions of vaccine doses for poor countries. But more will be needed and I hope wealthy nations will continue to be generous.”  

The World Bank unveiled plans this week for a significant financial commitment to support developing countries to purchase COVID-19 vaccines as soon as they are available. 

World Bank President David Malpass said that once the plans are ratified by stakeholders, “having up to US$ 12 billion available in finance will be a game changer because once a safe and effective vaccine is available, it will allow people to resume their lives with confidence.” 

Investing in Global Recovery

The ACT-Accelerator Investment Case illustrates the considerable economic benefits of collectively accelerating the development and deployment of tools to rapidly reduce the risk of severe COVID-19 disease globally. Prior to UNGA 2020, the ACT-Accelerator has raised US$3 billion out of a need of US$38 billion. More detail can be found in the Act-Accelerator investment case.

The economic rationale for investing in an approach that can accelerate the end of the COVID-19 crisis remains clear. Fully financing the initiative to help shorten the duration of the crisis would pay back this investment in less than 36 hours once global mobility and trade alone are restored. 

Notes to Editors

The Access to COVID-19 Tools ACT-Accelerator, is the proven, up-and-running global collaboration to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines. It was set up in response to a call from G20 leaders in March and launched by the WHO, European Commission, France and The Bill & Melinda Gates Foundation in April 2020.

The ACT-Accelerator is not a decision-making body or a new organization, it  works to speed up collaborative efforts among existing organizations to end the pandemic. It is a framework for collaboration that has been designed to bring key players around the table with the goal of ending the pandemic as quickly as possible through the accelerated development, equitable allocation, and scaled up delivery of tests, treatments and vaccines, thereby protecting health systems and restoring societies and economies in the near term.

It draws on the experience of leading global health organizations which are tackling the world’s toughest health challenges, and who, by working together, are able to unlock new and more ambitious results against COVID-19. Its members share a commitment to ensure all people have access to all the tools needed to defeat COVID-19 and to work with unprecedented levels of partnership to achieve it. 

The ACT-Accelerator comprises four pillars: diagnostics, therapeutics, vaccines and health system strengthening.

The diagnostics pillar, co-convened by the Global Fund and FIND, is focused on bringing to market 2–3 high-quality rapid tests, training 10 000 healthcare professionals across 50 countries and establishing testing for 500 million people in Low and Middle-Income countries by mid-2021. 

The therapeutics pillar is led by Unitaid and The Wellcome Trust. Therapeutics can play a role in all stages of COVID-19 disease: to prevent infection; suppress symptoms and spread of infection to others; treat or prevent symptoms; as a life-saving treatment for severe symptoms; and as a treatment that can speed up recovery. The aim in the next 12 months is to develop, manufacture and distribute 245 million treatments, helping COVID-19 sufferers to recover from the disease. 

The vaccines pillar, convened by CEPI, Gavi and WHO, is speeding up the search for an effective vaccine for all countries. At the same time, it is supporting the building of manufacturing capabilities, and buying supply, ahead of time so that 2 billion doses can be fairly distributed by the end of 2021.

The health systems connector pillar, led by the World Bank and the Global Fund, is working to ensure that these tools can reach the people who need them.

Cross cutting all of these is the workstream on Access & Allocation, hosted by the World Health Organization.

For more information, please visit:

WHO ACT-Accelerator Website: who.int/initiatives/act-accelerator

Status Report & Plan: bit.ly/ACTAcceleratorStatusReport

Economic Investment Case: bit.ly/ACTAcceleratorInvestmentCase

UN COVID-19 Response Portal: un.org/en/coronavirus

Archived video of the event is available on UN Web TV

 

Uncategorised

NEW DNC VIDEO: ‘Had Enough?’

30 Sep

The DNC War Room today released a new video, “Had Enough?”, to highlight some of the chaos Trump brought to the debate last night, filled with desperate lies, outbursts, interruptions, and incitements of hate groups.

“Trump made it clear last night he lacks the leadership and temperament that Americans across the country are looking for in their president,” said DNC War Room Senior Spokesperson and Advisor Lily Adams. “He couldn’t go two minutes without some desperate display of lying, ranting, whining, or bullying. He couldn’t even bring himself to disown white supremacist groups that threaten our nation. Joe Biden said it best of Trump and the chaos he has created, ‘It is what it is because you are who you are.’”

The post NEW DNC VIDEO: ‘Had Enough?’ appeared first on Democrats.